0 a condition in which someone can see things clearly that are far away but not things that are near
Therefore, if one deliberately operates only on one eye, the possibility of correcting high myopia or hyperopia will be lost.
At high concentrations, it also prevented hyperopia development.
No effect of the glucagon antagonist on hyperopia development was visible at the lower and the higher dose.
In contrast, the brother remains hyperopia and has exhibited no specific retinal findings until age 18 years.
The glucagon antagonist inhibited hyperopia development, albeit only in a narrow concentration range, and at most by 50%, but not myopia development.
For instance, two boys had mild or low hyperopia, one had myopia, and one had a relatively important astigmatism.
This pedigree could be a model for hyperopia, a common condition affecting approximately 25% of the human population.
What ocular components underlie the inhibition of myopia or hyperopia by glucagon or by its antagonist?